Low body mass index and use of corticosteroids, but not cholestasis, are risk factors for osteoporosis in patients with chronic liver disease
- 1 July 1999
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 31 (1) , 84-90
- https://doi.org/10.1016/s0168-8278(99)80167-6
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosisJournal of Hepatology, 1996
- A controlled study of bone mineral density in patients with inflammatory bowel disease.Gut, 1995
- Nutritional assessment in primary biliary cirrhosis: the effect of disease severityClinical Nutrition, 1995
- A controlled trial of prednisolone treatment in primary biliary cirrhosisJournal of Hepatology, 1992
- Bone loss after liver transplantationHepatology, 1991
- Prevalence and Prediction of Osteopenia in Chronic Liver DiseaseHepatology, 1990
- Osteoporosis and skeletal fractures in chronic liver disease.Gut, 1990
- Bone disease after orthotopic liver transplantationJournal of Hepatology, 1988
- Vitamin D prophylaxis and osteomalacia in chronic cholestatic liver diseaseDigestive Diseases and Sciences, 1980
- Transection of the oesophagus for bleeding oesophageal varicesBritish Journal of Surgery, 1973